Jubilant Pharma: Funding, Investors & Team (Oct 2026)

Blissful Pharma Limited is an organization focused on giving answers for the drugs business across the worth chain. It is an auxiliary of Jubilant Life Sciences, an incorporated worldwide drug and life sciences organization. The Company gives answers for worldwide drug clients, offering a great many items and administrations. Upbeat Pharma , is participated in assembling and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile and Non-sterile items through six USFDA endorsed fabricating offices in India, USA and Canada. The Company's prosperity is a result of broad innovative work in the drug space, which empowered it to climb the drug esteem chain for items and administrations across geologies. Glad has been continually putting resources into different development stages in this manner advancing a culture of advancement. At Jubilant Pharma, it is steady undertakings to work on the items and cycles, to hoist the nature of creation and cost intensity and to assemble an incentive for its clients. The Company has enhanced the business by building capacities inside, through essential extensions and acquisitions, in this manner, creating organization of elite assembling offices in India (two) and in North America (four). Settled in Singapore it has a committed group of around 4300 individuals across the globe and has expanded its scope universally with ground presence in India, North America and Europe. Happy Pharma's advancement in different organizations is a consequence of broad R&D. Development at Jubilant is upheld by solid science, biological science ability and the panoptic information procured throughout the long term. The Company has qualities in R&D through a solid logical group, current offices, control over reasonable advancements and economies of scale into a synergistic natural substance, in this manner, consistently creating and sustaining excellent items and advances. In accordance with Jubilant's relentless spotlight on manageability of business, it endeavors to further develop partner esteem through improved eco-effective utilization of capital and normal assets. In the Company's way to deal with reasonable turn of events, the pressure is laid on the triple primary concern of - Economics, Environment and Social execution. Glad Pharma has likewise promised towards chipping away at different regions for energy protection and environmental change moderation.

Jubilant Pharma has raised $400M across 1 round on record. The most recent is a Debt Financing of $400M announced in Jul 2022.

Jubilant Pharma's most recent funding round on record is a Debt Financing of $400M, announced in Jul 2022.

Giuliano Perfetti is listed as CEO at Jubilant Pharma.

Jubilant Pharma is based in Singapore, Central Region, Singapore.

Jubilant Pharma is in the 1-10 employee band.

Jubilant Pharma's latest round of $400M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.